Evidence map›Paper›PMID 40515421›Full record

ReviewImmunology2025

Should We Advance Our Understanding of Immunoglobulin E in Viral Immunity?

Amanda Izeli Portilho, Valéria Oliveira Silva, Luis Fernando de Macedo Brigido, Elizabeth De Gaspari

Abstract readReview
In one paragraph

Review in Immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amanda Izeli PortilhoImmunology Center, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.ORCID 0000-0003-0875-5910
Valéria Oliveira SilvaVirology Center, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.ORCID 0000-0002-5346-9633
Luis Fernando de Macedo BrigidoVirology Center, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.ORCID 0000-0002-1022-7837
Elizabeth De GaspariImmunology Center, Adolfo Lutz Institute, São Paulo, São Paulo, Brazil.ORCID 0000-0001-8332-2248

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305301/2022-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
6 · The paper itself

Abstract

Immunoglobulin E has been extensively studied in allergies and parasitic diseases. However, antigen-specific IgE has been identified as part of the humoral response to some viruses, including Respiratory syncytial virus (RSV), Human rhinovirus (HRV), Influenza, Hepatitis B virus (HBV), Human immunodeficiency virus (HIV), Herpes simplex virus (HSV), Dengue virus (DENV) and SARS-CoV-2. In this brief article, we have reviewed key aspects of IgE function and structure, and summarised the findings about this antibody in virus-specific immune response. To date, IgE effector mechanisms in the face of viruses have been almost unexplored through functional assays. We speculate on possible functionalities, such as neutralisation, cytotoxicity and immunopathology of viral diseases, and provide insights about gaps to fill in future research.

Indexed as

Antibodies, ViralImmunoglobulin EVirus DiseasesAnimalsHumansAntibodies, ViralImmunoglobulin Eantibody functionalityhumoral responseIgEimmune responseviruses

Identifiers

PMID40515421
PMCPMC12500387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.